West Pharmaceutical Services, Inc. News
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
see moreWest Pharmaceutical Services, Inc. Market News
8d
West Pharmaceutical Services Lifts Quarterly Dividend by 18%, Reflecting Shareholder Confidence
- West Pharmaceutical Services (WST) announced an 18% increase in its quarterly dividend to $0.26 per share, payable Nov. 18, signaling strong cash flow resilience.
15d
West Pharmaceutical to Showcase Packaging Leadership at CPHI Worldwide Amid Stable Operations
West Pharmaceutical Services will highlight its role in packaging and containment at CPHI Worldwide, underscoring its industry leadership amid stable fundamentals.
22d
West Pharmaceutical to Highlight Packaging Leadership at CPHI Worldwide 2026
West Pharmaceutical Services will underscore its global leadership in pharmaceutical packaging at CPHI Worldwide on October 5, signaling strategic visibility ahead of its Q3 call.
29d
West Pharmaceutical Services (WST) Sees No Material Events in Past Week Amid Seasonal Quiet
West Pharmaceutical Services (WST) showed no new material filings or announcements in the past week; most recent updates remain its Q2 results and a July material agreement.
28 Sep at 17:05
West Pharmaceutical Services Highlights Resilience Amid Cyber Disruption at Healthcare Conferences
West Pharmaceutical Services affirmed strong broad-based demand across high-value injectable packaging after its cyber incident, signaling resilience amid operational disruptions.